NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Researchers publish new studies and findings in the area of breast cancer



March 9th, 2006

New findings from the United States describe advances in breast cancer.

Study 1: According to recently published research from the United States, oncolytic adenovirotherapy and TRAIL gene therapy have a combined effect in syngeneic murine breast cancer models.

W. Guo and colleagues, M.D. Anderson Cancer Center, wrote, "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy and oncolytic adenovirotherapy have been investigated extensively in xerographic human tumor models established in immunocompromised nude mice. However, the effects of these therapies on syngeneic murine tumors in immunocompetent settings were not well...


Source: Women's Health Weekly (2006-03-09)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login